Decibel Therapeutics Return On Equity vs. EBITDA

DBTXDelisted Stock  USD 3.08  0.02  0.65%   
Based on Decibel Therapeutics' profitability indicators, Decibel Therapeutics may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Decibel Therapeutics' ability to earn profits and add value for shareholders.
For Decibel Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Decibel Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Decibel Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Decibel Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Decibel Therapeutics over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Please note, there is a significant difference between Decibel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decibel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decibel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Decibel Therapeutics EBITDA vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Decibel Therapeutics's current stock value. Our valuation model uses many indicators to compare Decibel Therapeutics value to that of its competitors to determine the firm's financial worth.
Decibel Therapeutics is rated below average in return on equity category among its peers. It is rated below average in ebitda category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Decibel Therapeutics' earnings, one of the primary drivers of an investment's value.

Decibel EBITDA vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Decibel Therapeutics

Return On Equity

 = 

Net Income

Total Equity

 = 
-0.77
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Decibel Therapeutics

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(62.49 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Decibel EBITDA Comparison

Decibel Therapeutics is currently under evaluation in ebitda category among its peers.

Decibel Therapeutics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Decibel Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Decibel Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Decibel Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Decibel Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Decibel Therapeutics, Inc. was incorporated in 2013 and is headquartered in Boston, Massachusetts. Decibel Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 62 people.

Decibel Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Decibel Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Decibel Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Decibel Therapeutics' important profitability drivers and their relationship over time.

Use Decibel Therapeutics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Decibel Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decibel Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Decibel Therapeutics Pair Trading

Decibel Therapeutics Pair Trading Analysis

The ability to find closely correlated positions to Decibel Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Decibel Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Decibel Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Decibel Therapeutics to buy it.
The correlation of Decibel Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Decibel Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Decibel Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Decibel Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Decibel Therapeutics position

In addition to having Decibel Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Entertainment Thematic Idea Now

Entertainment
Entertainment Theme
Companies from entertainment industry including show business, news and media. The Entertainment theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Entertainment Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Decibel Stock

If you are still planning to invest in Decibel Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Decibel Therapeutics' history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format